61324-93-4Relevant articles and documents
FUSED RING HETEROARYL COMPOUNDS AS RIPK1 INHIBITORS
-
Paragraph 0157, (2021/02/12)
The invention provides novel substituted heterocyclic compounds represented by Formula I, or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided c
TRPML MODULATORS
-
Paragraph 0549, (2021/06/26)
The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
INDAZOLE- AND PYRROLOPYRIDINE-DERIVATIVE AND PHARMACEUTICAL USE THEREOF
-
Page/Page column 184; 185, (2013/02/27)
The present invention relates to a novel indazole- or pyrrolopyridine-derivative, represented by the formula (1) below, that has an agonistic action or a partial agonistic action against serotonin-4 receptor, and a pharmaceutical composition comprising the same. Formula (1) [wherein each substituent is as defined in claim 1]
Palladium catalysed Suzuki reactions of fluoroarenes
Widdowson, David A.,Wilhelm, Rene
, p. 578 - 579 (2007/10/03)
A novel palladium catalysed cleavage of C-F bonds in a series of Suzuki reactions of aryl fluorides is described together with a discussion of the mechanistic implications.
ISOINDOLINYL-ALKYL-PIPERAZINES
-
, (2008/06/13)
The invention is generally concerned with isoindolinyl-alkylpiperazine compounds generally characterized by the formula STR1 wherein X is halogen or trifluoromethyl; n is an integer ranging from 2 to 5; Y is STR2 in which R 1 is hydrogen, halogen, lower alkyl, lower alkoxy, trifluoromethyl, cyano; R 2 is hydrogen, halogen, lower alkyl, lower alkoxy; and R 3 is hydrogen, cyano. These compounds are useful as diuretic and/or antihypertensive agents.